These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1864575)

  • 61. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Time to clozapine response in a standardized trial.
    Conley RR; Carpenter WT; Tamminga CA
    Am J Psychiatry; 1997 Sep; 154(9):1243-7. PubMed ID: 9286183
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Starting patients on clozapine in a partial hospitalization program.
    Johnson CG; Littrell KH; Magill AM
    Hosp Community Psychiatry; 1994 Mar; 45(3):264-8. PubMed ID: 8188200
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study.
    Alphs LD; Lee HS
    J Clin Psychiatry; 1991 Aug; 52(8):346-8. PubMed ID: 1869497
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [New drug therapies].
    Olié JP; Baylé FJ
    Encephale; 1996 Oct; 22 Spec No 3():63-71; discussion 76. PubMed ID: 8954280
    [No Abstract]   [Full Text] [Related]  

  • 67. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
    Stengler-Wenzke K
    Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Long-term clinical experience with clozapine].
    Gelly F; Chambon O; Marie-Cardine M
    Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical notes on clozapine.
    Mallott D; Monroe R
    Hosp Community Psychiatry; 1990 Aug; 41(8):890-1. PubMed ID: 2401479
    [No Abstract]   [Full Text] [Related]  

  • 71. Clozapine for first-episode schizophrenia.
    Kolivakis TT; Margolese HC; Beauclair L; Chouinard G
    Am J Psychiatry; 2002 Feb; 159(2):317. PubMed ID: 11823283
    [No Abstract]   [Full Text] [Related]  

  • 72. Clozapine and negative symptoms.
    Wing YK
    Br J Psychiatry; 1993 Jul; 163():121. PubMed ID: 8353681
    [No Abstract]   [Full Text] [Related]  

  • 73. Novel neuroleptics in schizophrenia: theory and clinical relevance.
    Remington GJ
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
    [No Abstract]   [Full Text] [Related]  

  • 74. Does clozapine affect smoking rates?
    Chatterton R; Sanderson L; Van Leent S; Plant K
    Aust N Z J Psychiatry; 1998 Dec; 32(6):890-1. PubMed ID: 10084360
    [No Abstract]   [Full Text] [Related]  

  • 75. [Value of neuroleptic therapy in the self assessment of schizophrenic patients].
    Heim M
    Psychiatr Neurol Med Psychol (Leipz); 1987 Aug; 39(8):487-91. PubMed ID: 3685210
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series.
    Se Hyun Kim ; Dong Chung Jung ; Yong Min Ahn ; Yong Sik Kim
    J Psychopharmacol; 2010 Jul; 24(7):981-6. PubMed ID: 19942641
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Double-blind study of clozapine dose response in chronic schizophrenia.
    Simpson GM; Josiassen RC; Stanilla JK; de Leon J; Nair C; Abraham G; Odom-White A; Turner RM
    Am J Psychiatry; 1999 Nov; 156(11):1744-50. PubMed ID: 10553738
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clozapine concentrations and clinical response in schizophrenic patients.
    Jeffries JJ
    Am J Psychiatry; 1991 Oct; 148(10):1406-7. PubMed ID: 1772490
    [No Abstract]   [Full Text] [Related]  

  • 79. Effect of clozapine on psychogenic polydipsia in chronic schizophrenia.
    Lee HS; Kwon KY; Alphs LD; Meltzer HY
    J Clin Psychopharmacol; 1991 Jun; 11(3):222-3. PubMed ID: 2066464
    [No Abstract]   [Full Text] [Related]  

  • 80. Three phases of clozapine treatment and phase-specific issues for patients and families.
    Kotcher M; Smith TE
    Hosp Community Psychiatry; 1993 Aug; 44(8):744-7. PubMed ID: 8375834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.